Offer - Urjas Oil for just ₹ 1 X
Zyrifa, a prescription drug, is manufactured in various forms such as Capsule. Primarily, it is used for the treatment of Tuberculosis.
The optimal dosage of Zyrifa is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Zyrifa are Hallucinations, Disorientation, Confusion. Some other side effects of Zyrifa have been listed ahead. Normally, these side effects of Zyrifa are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Zyrifa's effect is Moderate during pregnancy and Unknown for lactating mothers. It is important to know if Zyrifa has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Zyrifa related warnings section.
Other contraindications of Zyrifa have been discussed in the sections ahead.
Drug interactions for Zyrifa have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Zyrifa is considered not safe while driving, and is not addictive.
Zyrifa is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Zyrifa safe for pregnant women?
Pregnant women may experience moderate side effects from Zyrifa. It is best to stop taking Zyrifa immediately and inform your doctor if you notice any discomfort.
Is the use of Zyrifa safe during breastfeeding?
No research work has been carried out till date on effect of Zyrifa on breastfeeding women. So it is not known whether taking Zyrifa will cause side effects or not.
What is the effect of Zyrifa on the Kidneys?
Zyrifa may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Zyrifa on the Liver?
The liver can be affected by Zyrifa. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Zyrifa only after medical advice.
What is the effect of Zyrifa on the Heart?
There is no research available on the side effects of Zyrifa on the heart. Therefore, its impact is unknown.
Zyrifa should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Zyrifa unless your doctor advises you to do so -
Is this Zyrifa habit forming or addictive?
Zyrifa is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Zyrifa as you may feel sleepy.
Is it safe?
Zyrifa is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Zyrifa is not used to treat mental disorders.
Interaction between Food and Zyrifa
Due to a lack of research, nothing can be said about the consequences of taking Zyrifa together with food.
Interaction between Alcohol and Zyrifa
Taking alcohol with Zyrifa can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Myambutol (ethambutol hcl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 535-536
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 768-769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1066-1067